Exclusive-US pharma tariffs would raise US drug costs by $51 billion annually, report finds
By Maggie Fick LONDON (Reuters) -A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S. prices by as much as 12.9% i...
Roaring 2020s scenario might be back on track soon: Yardeni
Investing.com -- Yardeni Research says its long-standing “Roaring 2020s” scenario could be regaining momentum after recent market turbulence. In a note published April 24, analysts p...
Wall Street set for weekly gains with trade signals, earnings in focus
By Lisa Pauline Mattackal and Purvi Agarwal (Reuters) -Wall Street’s main indexes were on track for weekly gains on Friday, though they struggled for direction on the day as investor...
